Clinical trialNCT00660660CompletedPhase 4Interventional

Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US

SponsorAstraZenecaEnrollment276Gastroesophageal Reflux Disease

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

David Johnson, MD
Eastern Virginia Medical School
Principal Investigator
clinicaltrials.gov ↗
Kurt Brown, MD
AstraZeneca
Study Director
clinicaltrials.gov ↗
Tore Lind, MD
AstraZeneca
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

45 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Research Site
Huntsville, Alabama, United States
Research Site
Tucson, Arizona, United States
Research Site
Little Rock, Arkansas, United States
Research Site
Anaheim, California, United States
Research Site
Burbank, California, United States
Research Site
Castro Valley, California, United States
Research Site
Orange, California, United States
Research Site
San Diego, California, United States
Research Site
Boynton Beach, Florida, United States
Research Site
Coral Springs, Florida, United States
Research Site
DeLand, Florida, United States
Research Site
Hollywood, Florida, United States
Research Site
Jupiter, Florida, United States
Research Site
Pembroke Pines, Florida, United States
Research Site
South Miami, Florida, United States
Research Site
Tampa, Florida, United States
Research Site
Zephyrhills, Florida, United States
Research Site
Stockbridge, Georgia, United States
Research Site
Overland Park, Kansas, United States
Research Site
Lexington, Kentucky, United States
Research Site
Hollywood, Maryland, United States
Research Site
Las Vegas, Nevada, United States
Research Site
Medford, New Jersey, United States
Research Site
Perth Amboy, New Jersey, United States
Research Site
West Orange, New Jersey, United States
Research Site
Albuquerque, New Mexico, United States
Research Site
Binghamton, New York, United States
Research Site
Huntersville, North Carolina, United States
Research Site
Raleigh, North Carolina, United States
Research Site
Winston-Salem, North Carolina, United States
Research Site
Cincinnati, Ohio, United States
Research Site
Dayton, Ohio, United States
Research Site
Kettering, Ohio, United States
Research Site
Oklahoma City, Oklahoma, United States
Research Site
Chattanooga, Tennessee, United States
Research Site
Johnson City, Tennessee, United States
Research Site
Amarillo, Texas, United States
Research Site
Fort Worth Dallas, Texas, United States
Research Site
Houston, Texas, United States
Research Site
Ogden, Utah, United States

5 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Apr 2008
Primary completion: 31 Jul 2008
Completion: 31 Jul 2008
Last update posted: 2 Mar 2015
Registered enrollment: 276
Registry id: NCT00660660

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.